When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYDY - CytoDyn's PRO 140 continues to show positive action in HIV
CytoDyn Inc
CytoDyn (OTCQB:CYDY) announces that new data show that weekly doses of 525 mg and 700 mg of leronlimab (PRO 140) in HIV-1-positive patients produced a 90% response rate in patients who passed the first 10 weeks of monotherapy without virologic failure.
More news on: CytoDyn Inc., Healthcare stocks news,